Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.36 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL56403 | 0.89 | TSHR (0.63) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL11131919 | 0.88 | TSHR (0.65) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| Glycerin SCHEMBL17711591 | 0.88 | TSHR (0.47) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL29207431 | 0.86 | TSHR (0.61) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL28545578 | 0.86 | TSHR (0.61) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL11585580 | 0.86 | TSHR (0.73) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL12944731 | 0.85 | TSHR (0.56) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| Methacrylic Acid SCHEMBL22345178 | 0.83 | TSHR (0.55) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL8816347 | 0.83 | TSHR (0.58) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL3804106 | 0.83 | TSHR (0.63) | TSHRTDP1SMN1; SMN2PKMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 353 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118302403-A | Process for forming alkyl esters of levulinic acid | 巴斯夫欧洲公司 | 2024-07-05 | — | — | CN | claimed |
| CN-118234379-A | Preservative composition | 阿尔萨达股份公司 | 2024-06-21 | — | — | CN | claimed |
| EP-4367087-A1 | SEPARATION PROCESS FOR THE PRODUCTION OF C5 OR C6 ALKANEDIOL | Johnson Matthey Davy Technologies Limited (GB) | 2024-05-15 | — | — | EP | claimed |
| EP-4355892-A1 | PREPARING DIESTERS OF MALONIC ACID | Lygos, Inc. (US) | 2024-04-24 | — | — | EP | claimed |
| CN-117440941-A | For the production of C 5 Or C 6 Process for the separation of alkanediol | 庄信万丰戴维科技有限公司 | 2024-01-23 | — | — | CN | claimed |
| US-20230365485-A1 | PROCESS FOR PRODUCING LEVULINIC ACID | BIO ON S.P.A. (IT) | 2023-11-16 | — | — | US | claimed |
| EP-4217336-A1 | PROCESS FOR PRODUCING LEVULINIC ACID | Bio-On S.p.A. (IT) | 2023-08-02 | — | — | EP | claimed |
| CN-116529232-A | Process for producing levulinic acid | 博奥股份公司 | 2023-08-01 | — | — | CN | claimed |
| WO-2023281247-A1 | SEPARATION PROCESS FOR THE PRODUCTION OF C5 OR C6 ALKANEDIOL | JOHNSON MATTHEY DAVY TECHNOLOGIES LIMITED (GB) | 2023-01-12 | — | — | WO | claimed |
| WO-2022265934-A1 | PREPARING DIESTERS OF MALONIC ACID | LYGOS, INC. (US) | 2022-12-22 | — | — | WO | claimed |
| WO-2007012585-A1 | FUEL COMPOSITIONS | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2007-02-01 | — | — | WO | claimed |
| WO-2007012586-A1 | FUEL COMPOSITIONS | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2007-02-01 | — | — | WO | claimed |
| CN-1886488-A | Fuel compositions comprising a c4-c8 alkyl levulinate | SHELL INT RESEARCH (NL) | 2006-12-27 | — | — | CN | claimed |
| US-20060247443-A1 | Process for making 5-methyl -N-alkyl-2-pyrrolidone from alkyl amines and alkyl levulinate esters | E. I. DU PONT DE NEMOURS AND COMPANY | 2006-11-02 | — | — | US | claimed |
| EP-1685217-A1 | FUEL COMPOSITIONS COMPRISING A C4-C8 ALKYL LEVULINATE | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 2006-08-02 | — | — | EP | claimed |
| US-20050144835-A1 | Fuel compositions | SHELL OIL COMPANY | 2005-07-07 | — | — | US | claimed |
| WO-2005044960-A1 | FUEL COMPOSITIONS COMPRISING A C4-C8 ALKYL LEVULINATE | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2005-05-19 | — | — | WO | claimed |
| US-20040231233-A1 | Fuel composition | AAE TECHNOLOGIES INTERNATIONAL PLC (IE) | 2004-11-25 | — | — | US | claimed |
| WO-2003002696-A1 | FUEL COMPOSITION | AAE TECHNOLOGIES INTERNATIONAL PLC (IE) | 2003-01-09 | — | — | WO | claimed |
| US-5518585-A | Neutral sizing agent for base paper stuff with the use of cationic plastics dispersions | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-05-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060247443-A1 | Process for making 5-methyl -N-alkyl-2-pyrrolidone from alkyl amines and alkyl levulinate esters | ALDH18A1, ADH5, PRMT5 | TSHR 3061/4885TDP1 2155/4885SMN1; SMN2 1671/4885 |
| US-20230365485-A1 | PROCESS FOR PRODUCING LEVULINIC ACID | HPSE, LDHA, LCT | TSHR 2483/4885TDP1 2505/4885SMN1; SMN2 4057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.